Liposomal Methylprednisolone in Rats: Dose-Proportionality and Chronic-Dose Pharmacokinetics/Pharmacodynamics

Pharmaceutical Research

Volumn 13, Issue 1, 1996, Pages 141-145

  Mishina, Elena V ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Dose dependence; Liposomes; Methylprednisolone; Multiple doses; Pharmacodynamics; Pharmacokinetics

Indexed keywords

LIPOSOME; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; IMMUNOSUPPRESSIVE AGENTS; LIPOSOMES; MALE; METHYLPREDNISOLONE; RATS; RATS, INBRED LEW; SPLEEN; TIME FACTORS;

EID: 0029928833     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016054022750     Document Type: Article

References (14)

1. D.E. Brenner. Liposomal encapsulation: making old and new drugs do new tricks. J. Nat. Cancer Inst. 81: 1480-1483 (1989).
2. E.V. Mishina, R.M. Straubinger, N.A. Pyszczynski, W.J. Jusko. Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulation. Pharm. Res. 10: 1402-1410 (1993).
3. E.V. Mishina, and W.J. Jusko. Inhibition of rat splenocyte proliferation with methylprednisolone: in vivo effect of liposomal formulation. Pharm. Res. 11: 848-854 (1994).
4. E.V. Mishina, J. Binder, J.W. Kupiec-Weglinski and W.J. Jusko. Effect of liposomal methylprednisolone on heart allograft survival and immune function in rats. J. Exper. Pharmacol. Ther. 271: 868-874 (1994)
5. J. Binder, E.V. Mishina, W.J. Jusko and J.W. Kupiec-Weglinski. Prolongation of cardiac allograft survival in rats by liposome- encapsulated methylprednisolone. Transplantation 58: 633-635 (1994).
6. W.J. Jusko. Pharmacokinetics of capacity-limited systems. J. Clin. Pharmacol. 29: 488-493 (1989).
7. A.-N. Kong and W.J. Jusko. Disposition of methylprednisolone and its sodium succinate prodrug in vivo and in perfused liver of rats: nonlinear and sequential first-pass elimination. J. Pharm. Sci. 80: 409-415 (1991).
8. D.D. Lasic and D. Papahadjopoulos. Liposomes revisited. Science 267: 1275-1276 (1995).
9. Y. Kume, F. Maeda, H. Harashima and H. Kiwada. Saturable, non-Michaelis-Menten uptake of liposomes by the reticuloendothelial system. J. Pharm. Pharmacol. 43: 162-166 (1991).
10. H.B. Waynforth. Experimental and Surgical Technique in the Rat, Academic Press, London, 1980.
11. D.B. Haughey and W.J. Jusko. Analysis of methylprednisolone, methylprednisolone, and corticosterone for assessment of methylprednisolone disposition in rats. J. Chromatogr. 430: 241-248 (1988).
12. H. Harashima, N. Hirai and H. Kiwada. Kinetic modelling of liposome degradation in peritoneal macrophages. Biopharm. Drug Disp. 16: 113-123 (1995).
13. H.G. Eichler, J. Senior, A. Stadler, S. Gasic, P. Pfundner, and G. Gregoriadis. Kinetics and disposition of fluorescein-labelled liposomes in healthy human subjects. Eur. J. Clin. Pharmacol. 34: 475-479 (1988).
14. N. Badiola A.N.A. Al-Angary, G. W. Halbert. The effect of intravenous pretreatment with small liposomes on the pharmacokinetics and metabolism of antipyrine in rabbits. J. Pharm. Pharmacol. 44: 366-368 (1992).